Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 16493009

Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2006 Jun 1
First author
Loh ML

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Loh ML
      type
      Author
    2. name
      Goldwasser MA
      type
      Author
    3. name
      Silverman LB
      type
      Author
    4. name
      Poon WM
      type
      Author
    5. name
      Vattikuti S
      type
      Author
    6. name
      Cardoso A
      type
      Author
    7. name
      Neuberg DS
      type
      Author
    8. name
      Shannon KM
      type
      Author
    9. name
      Sallan SE
      type
      Author
    10. name
      Gilliland DG
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Loh ML
      type
      Author
    2. name
      Goldwasser MA
      type
      Author
    3. name
      Silverman LB
      type
      Author
    4. name
      Poon WM
      type
      Author
    5. name
      Vattikuti S
      type
      Author
    6. name
      Cardoso A
      type
      Author
    7. name
      Neuberg DS
      type
      Author
    8. name
      Shannon KM
      type
      Author
    9. name
      Sallan SE
      type
      Author
    10. name
      Gilliland DG
      type
      Author
    bibliography ids
    1. nci-bib-cf6ac738fa32614f9e64b291
    book metadata
    content sha256
    ec17f5f519fde9e1d6ca9f1f476b1fd7c08b08ca91206ee3d573794aa1074867
    document type
    citation
    dois
    1. 10.1182/blood-2005-08-3451
    electronic publication date
    display
    2006 Feb 21
    precision
    day
    year
    2006
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:16493009
    immutable id
    pubmed:16493009@ec17f5f519fde9e1d6ca9f1f476b1fd7c08b08ca91206ee3d573794aa1074867
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    11
    name
    Blood
    nlm unique id
    7603509
    pages
    4508-13
    volume
    107
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      16493009
      provenance
      batch id
      a181c30258a88d182e78
      provider
      NCBI PubMed ESummary
      record sha256
      de503c6f8a74599b5f479c87dba19153bd2b9b8191d6686411073afaad5b8d08
      response sha256
      558e0dce453ae424567844b062522ebd1d27363c3312c81dbf6f32a8ff08da24
      retrieved at
      2026-09-09T23:46:03.896343+00:00
      publication date
      display
      2006 Jun 1
      precision
      day
      year
      2006
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/16493009/
      title
      Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01.

      Preserved source evidence · Independent clinical review pending · Not medical advice